Asset
ANTITHROMBIN III HUMAN
Grifols S.A. American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00823082 | phase2 | completed | 2009-06-01 | 2011-06-01 | Instituto Grifols, S.A. | Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| BLA 103196 | BLA | Grifols Therapeutics LLC |
Marketed products (1)
- Thrombate Iii